CTLA4 and neoplasm: Immune checkpoints such as cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and programmed cell death ligand-1 (PD-L1) have been shown to impede anti-tumor immunity, leading to the invasion of host immune attack [10,11].